MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025
ROCKVILLE, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform...
ROCKVILLE, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform...
Launch Follows IM8’s Record Growth to $6.6 Million Monthly Revenue in September IM8 Accelerates Toward $100 Million ARR Milestone with...
Strategic collaboration with leading global manufacturer of drug delivery systems strengthens NS002's clinical and commercial roadmap with end-to-end development support...
PARAMUS, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with...
New 5-Pillar Framework Promises to Transform Scattered Compliance Records Into Audit-Ready Systems NEW YORK, Oct. 8, 2025 /PRNewswire/ -- Compliancy Group,...
The DEA Regulatory Revolving Door Spins AgainAfter years of blocking FDA approved cannabis research for Huntington's and Multiple Sclerosis, former...
PALO ALTO, CALIFORNIA / ACCESS Newswire / October 8, 2025 / Bioz, Inc, a pioneer in AI-driven citation management, is...
Appointment of Executive Chairman, proposed change of name and strategy updateCompany to pursue revised strategy and name change to CelLBxHealth...
DENVER, Oct. 7, 2025 /PRNewswire/ -- Partners in Pediatrics ("PIP") is providing notice of a recent data security incident that...